Fellowship · Detroit, MI
Sponsored by Detroit Medical Center
Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer imaging.
IEEE photonics journal · 2021 · 196 citations · Ira Winer
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 148 citations · Ira Winer
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
The Lancet. Oncology · 2024 · 64 citations · Ira Winer
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).
Clinical cancer research : an official journal of the American Association for Cancer Research · 2025 · 20 citations · Ira Winer
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 82 citations · Ira Winer
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer.
Journal for immunotherapy of cancer · 2025 · 14 citations ·
Neuroendocrine tumors of the gynecologic tract update.
Gynecologic oncology · 2021 · 52 citations · Ira Winer
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma.
Investigational new drugs · 2024 · 32 citations · Ira Winer